drugset / Trial / NCT00780832
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to anticholinergic therapy. We hope to show a reduction in symptoms with caffeine reduction and determine how effective caffeine reduction is compared to medication. If caffeine reduction is shown to be beneficial, women may be encouraged to use this strategy before resorting to medications.
Timeline
- Start
- 2008-05
- Primary completion
- 2012-12
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolterodine | Small molecule | 4 mg | Oral |